Physician profile
Dawn Murray
NPI 1144213059
$776.76
in general payments reported to CMS, 2019-2025
9 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.47 · 2023: $234 · 2024: $336 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $329.63 | 2023-2025 | Yeztugo, Epclusa |
| Viiv Healthcare Company | $231.30 | 2023-2024 | Apretude, Dovato |
| Theratechnologies INC. | $47.48 | 2023 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $37.60 | 2024 | Delstrigo, Pifeltro |
| Janssen Biotech, INC. | $32.10 | 2023 | Symtuza |
| Astellas Pharma US INC | $32.06 | 2025 | Veozah |
| Lilly USA, LLC | $30.47 | 2021 | |
| Organon LLC | $22.02 | 2024 | |
| Abbott Laboratories | $14.10 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.